Chia Victoria M, Newcomb Polly A, Bigler Jeannette, Morimoto Libby M, Thibodeau Stephen N, Potter John D
Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.
Cancer Res. 2006 Jul 1;66(13):6877-83. doi: 10.1158/0008-5472.CAN-06-1535.
Smoking has been consistently associated with an increased risk of colorectal adenomas and hyperplastic polyps as well as colorectal cancer. Conversely, nonsteroidal anti-inflammatory drugs (NSAID) have been associated with reduced colorectal cancer risk. We conducted a population-based case-control study to evaluate the joint association between smoking and regular NSAID use with colorectal cancer risk; we also examined these associations stratified by tumor microsatellite instability (MSI). We analyzed 1,792 incident colorectal cancer cases and 1,501 population controls in the Seattle, Washington area from 1998-2002. MSI, defined as MSI high (MSI-H) or MSI-low/microsatellite stable (MSI-L/MSS), was assessed in tumors of 1,202 cases. Compared with nonsmokers, colorectal cancer risk was modestly increased among individuals who had ever smoked. Current NSAID use was associated with a 30% lower risk compared with nonusers. There was a statistically significant interaction between smoking duration and use of NSAIDs (P(interaction) = 0.05): relative to current NSAID users who never smoked, individuals who had both smoked for >40 years and had never used NSAIDs were at the highest risk for colorectal cancer (adjusted odds ratio, 2.8; 95% confidence intervals, 1.8-4.1). Compared with nonsmokers, there was a stronger association within MSI-H tumors with current smoking than there was within MSI-L/MSS tumors. Smokers of long duration were at elevated risk of MSI-H tumors even with NSAID use. The risk of MSI-L/MSS tumors was not elevated among long-duration smokers with long exposure to NSAIDs but was elevated among long-duration smokers who had never used NSAIDs. There seems to be a synergistic inverse association (implying protection) against colorectal cancer overall as a result of NSAID use and nonsmoking, but risk of MSI-H colorectal cancer remains elevated among smokers even when they have a history of NSAID use.
吸烟一直与结直肠腺瘤、增生性息肉以及结直肠癌风险增加相关。相反,非甾体抗炎药(NSAID)与结直肠癌风险降低相关。我们开展了一项基于人群的病例对照研究,以评估吸烟与规律使用NSAID联合对结直肠癌风险的影响;我们还按肿瘤微卫星不稳定性(MSI)进行分层来研究这些关联。我们分析了1998年至2002年在华盛顿州西雅图地区的1792例新发结直肠癌病例和1501例人群对照。对1202例病例的肿瘤进行了MSI评估,MSI分为高微卫星不稳定性(MSI-H)或低微卫星不稳定性/微卫星稳定(MSI-L/MSS)。与不吸烟者相比,曾经吸烟的个体患结直肠癌的风险略有增加。与未使用者相比,当前使用NSAID与风险降低30%相关。吸烟时长与NSAID使用之间存在统计学显著的交互作用(P(交互作用)=0.05):相对于从未吸烟的当前NSAID使用者,既吸烟超过40年又从未使用过NSAID的个体患结直肠癌的风险最高(调整后的优势比为2.8;95%置信区间为1.8 - 4.1)。与不吸烟者相比,MSI-H肿瘤中当前吸烟的关联比MSI-L/MSS肿瘤中更强。即使使用NSAID,长期吸烟者患MSI-H肿瘤的风险也会升高。长期大量使用NSAID的长期吸烟者中,MSI-L/MSS肿瘤的风险并未升高,但从未使用过NSAID的长期吸烟者中该风险升高。总体而言,NSAID使用和不吸烟似乎对结直肠癌存在协同的反向关联(意味着有保护作用),但即使有NSAID使用史,吸烟者患MSI-H结直肠癌的风险仍然升高。